Organogenesis Holdings Inc. (ORGO): Price and Financial Metrics
ORGO Price/Volume Stats
| Current price | $2.84 | 52-week high | $4.70 |
| Prev. close | $2.76 | 52-week low | $1.79 |
| Day low | $2.75 | Volume | 127,114 |
| Day high | $2.90 | Avg. volume | 750,570 |
| 50-day MA | $3.09 | Dividend yield | N/A |
| 200-day MA | $3.11 | Market Cap | 374.77M |
ORGO Stock Price Chart Interactive Chart >
Organogenesis Holdings Inc. (ORGO) Company Bio
Organogenesis Holdings Inc. operates as a holding company. The Company, through its subsidiaries, focuses on development, manufacturing, and commercializing drugs and medicines for wound care, surgical, and sports medicine markets. Organogenesis Holdings serves customers in the United States and Switzerland.
Latest ORGO News From Around the Web
Below are the latest news stories about ORGANOGENESIS HOLDINGS INC that investors may wish to consider to help them evaluate ORGO as an investment opportunity.
Organogenesis (ORGO) is a Great Momentum Stock: Should You Buy?Does Organogenesis (ORGO) have what it takes to be a top stock pick for momentum investors? Let's find out. |
Organogenesis Holdings Inc. (NASDAQ:ORGO) Surges 42% Yet Its Low P/S Is No Reason For ExcitementOrganogenesis Holdings Inc. ( NASDAQ:ORGO ) shares have continued their recent momentum with a 42% gain in the last... |
Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Stock Is Going Strong: Have Financials A Role To Play?Organogenesis Holdings (NASDAQ:ORGO) has had a great run on the share market with its stock up by a significant 27... |
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2023 Earnings Call TranscriptOrganogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2023 Earnings Call Transcript November 9, 2023 Organogenesis Holdings Inc. beats earnings expectations. Reported EPS is $0.09075, expectations were $0.01. Operator: Welcome, ladies and gentlemen, to the Third Quarter of Fiscal Year 2023 Earnings Conference Call for Organogenesis Holdings Inc. [Operator Instructions]. Please note that this conference call is being […] |
The recent US$46m market cap decrease is likely to have disappointed insiders invested in Organogenesis Holdings Inc. (NASDAQ:ORGO)Key Insights Organogenesis Holdings' significant insider ownership suggests inherent interests in company's expansion... |
ORGO Price Returns
| 1-mo | -0.35% |
| 3-mo | -26.61% |
| 6-mo | 21.89% |
| 1-year | 37.86% |
| 3-year | -86.77% |
| 5-year | -63.64% |
| YTD | -30.56% |
| 2023 | 52.04% |
| 2022 | -70.89% |
| 2021 | 22.71% |
| 2020 | 56.55% |
| 2019 | N/A |
Continue Researching ORGO
Want to see what other sources are saying about Organogenesis Holdings Inc's financials and stock price? Try the links below:Organogenesis Holdings Inc (ORGO) Stock Price | Nasdaq
Organogenesis Holdings Inc (ORGO) Stock Quote, History and News - Yahoo Finance
Organogenesis Holdings Inc (ORGO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...